Consun Pharmaceutical Group Limited (stock code: 01681) reported a share repurchase in its Next Day Disclosure Return dated 13 February 2026. The company’s issued share count decreased from 841.51 million shares to 841.41 million shares following the cancellation of 100,000 repurchased shares on 12 February 2026.

The repurchase represents approximately 0.0119% of the company’s previously issued shares. The repurchase price was disclosed at HKD 15.505 per share, and the transaction took place on 6 January 2026, with the cancellation finalized on 12 February 2026. After the adjustment, the total issued shares stand at 841.41 million.